Difference between revisions of "Tegafur and uracil (UFT)"
m (→References) |
m |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> |
| + | |||
| + | ==Patient safety== | ||
| + | EMA has recommended that patients should be tested for the lack of the enzyme dihydropyrimidine dehydrogenase (DPD) before starting cancer treatment with fluorouracil given by injection or infusion (drip) or with the related medicines, capecitabine and tegafur. | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| − | *[[Colon cancer]] | + | *[[Colorectal cancer]] |
| + | **[[Colon cancer]] | ||
| + | **[[Rectal cancer]] | ||
*[[Esophageal cancer]] | *[[Esophageal cancer]] | ||
| + | *[[Gastric cancer]] | ||
| + | *[[Head and neck cancer]] | ||
| + | *[[Non-small cell lung cancer]] | ||
| + | **[[Non-small cell lung cancer, nonsquamous]] | ||
==Patient drug information== | ==Patient drug information== | ||
| Line 17: | Line 26: | ||
==Also known as== | ==Also known as== | ||
| − | Ftorafur, Tefudex | + | *'''Generic name:''' tegafur-uracil |
| + | *'''Brand names:''' Ftorafur, Luporal, Tefudex, Ufur, Uftoral, Uracel | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| − | [[Category: | + | [[Category:Drugs]] |
| − | [[Category: | + | [[Category:Combination drugs]] |
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
[[Category:Fluoropyrimidines]] | [[Category:Fluoropyrimidines]] | ||
| + | [[Category:Colorectal cancer medications]] | ||
[[Category:Colon cancer medications]] | [[Category:Colon cancer medications]] | ||
[[Category:Esophageal cancer medications]] | [[Category:Esophageal cancer medications]] | ||
| + | [[Category:Gastric cancer medications]] | ||
| + | [[Category:Head and neck cancer medications]] | ||
| + | [[Category:Non-small cell lung cancer medications]] | ||
| + | [[Category:Non-small cell lung cancer, nonsquamous medications]] | ||
| + | [[Category:Rectal cancer medications]] | ||
[[Category:PMDA approved drugs]] | [[Category:PMDA approved drugs]] | ||
Revision as of 01:18, 7 November 2023
Note: this drug combination is not FDA approved but is used widely in other countries.
General information
Class/mechanism: Contains a fixed molar ratio (4:1) of uracil to tegafur. Tegafur is metabolized in vivo to Fluorouracil (5-FU), which is a pyrimidine analog antimetabolite that is metabolized to 5-fluoro-2'-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). FdUMP inhibits DNA synthesis by binding to thymidylate synthase and inhibiting production of thymidylate; FUTP interferes with RNA processing when it is mistakenly incorporated in place of uridine triphosphate (UTP). Uracil helps to maintain intracellular levels of Fluorouracil (5-FU) by inhibiting its degradation.[1][2][3]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient safety
EMA has recommended that patients should be tested for the lack of the enzyme dihydropyrimidine dehydrogenase (DPD) before starting cancer treatment with fluorouracil given by injection or infusion (drip) or with the related medicines, capecitabine and tegafur.
Diseases for which it is used
Patient drug information
- Uracil-tegafur (UFT) patient information site[4]
- Macmillan Uracil-tegafur (UFT) patient information[5]
Also known as
- Generic name: tegafur-uracil
- Brand names: Ftorafur, Luporal, Tefudex, Ufur, Uftoral, Uracel
References
- Drugs
- Combination drugs
- Oral medications
- Fluoropyrimidines
- Colorectal cancer medications
- Colon cancer medications
- Esophageal cancer medications
- Gastric cancer medications
- Head and neck cancer medications
- Non-small cell lung cancer medications
- Non-small cell lung cancer, nonsquamous medications
- Rectal cancer medications
- PMDA approved drugs